Hazardous substances, the environment and public health: a statistical overview.

por Hunter, W G, Crowley, J J
Publicado 1979

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis

por Crowley, J.J., Warren, R.B., Cather, J.C.
Publicado 2019

Baseline patient‐reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice

por Kimball, A.B., Crowley, J.J., Papp, K., Calimlim, B., Duan, Y., Fleischer, A.B., Sobell, J.
Publicado 2020

Reducing GHG emissions through genetic improvement for feed efficiency: effects on economically important traits and enteric methane production

por Basarab, J. A., Beauchemin, K. A., Baron, V. S., Ominski, K. H., Guan, L. L., Miller, S. P., Crowley, J. J.
Publicado 2013

Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase‐3, randomized, placebo‐controlled trial

por Elewski, B.E., Baker, C.S., Crowley, J.J., Poulin, Y., Okun, M.M., Calimlim, B., Geng, Z., Reyes Servin, O., Rich, P.A.
Publicado 2019

Genome-wide association analysis identifies common variants influencing infant brain volumes

por Xia, K, Zhang, J, Ahn, M, Jha, S, Crowley, J J, Szatkiewicz, J, Li, T, Zou, F, Zhu, H, Hibar, D, Thompson, P, Sullivan, P F, Styner, M, Gilmore, J H, Knickmeyer, R C
Publicado 2017

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded t...

por Blauvelt, A., Leonardi, C., Elewski, B., Crowley, J.J., Guenther, L.C., Gooderham, M., Langley, R.G., Vender, R., Pinter, A., Griffiths, C.E.M., Tada, Y., Elmaraghy, H., Lima, R.G., Gallo, G., Renda, L., Burge, R., Park, S.Y., Zhu, B., Papp, K.
Publicado 2020